SCHEMBL4842248

SCHEMBL4842248

COc1ccc2c(c1)C(=CC(=O)c1cccc(NC(=O)c3ccc(Cl)cc3Cl)c1)NC(C)(C)C2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
TP53 P04637 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
ALDH1A1 P00352 4/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
FADS1 O60427 1/20 0.42
CDYL2 Q8N8U2 1/20 0.42
CDYL Q9Y232 1/20 0.42
CDY1; CDY1B Q9Y6F8 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CES1 P23141 1/20 0.40
BACE1 P56817 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842240 1.00 MAPT (0.54) MAPTTP53L3MBTL1MEN1KMT2A
SCHEMBL4834457 0.92 KMT2A (0.53) MAPTTP53MEN1KMT2AALDH1A1
SCHEMBL4834466 0.92 KMT2A (0.53) MAPTTP53MEN1KMT2AALDH1A1
SCHEMBL4838335 0.91 MAPT (0.46) MAPTTP53MEN1KMT2ANPC1
SCHEMBL4838346 0.91 MAPT (0.46) MAPTTP53MEN1KMT2ANPC1
SCHEMBL4839972 0.90 RAB9A (0.41) MAPTTP53L3MBTL1MEN1KMT2A
SCHEMBL4839976 0.90 RAB9A (0.41) MAPTTP53L3MBTL1MEN1KMT2A
SCHEMBL4841134 0.90 RAB9A (0.48) MAPTTP53MEN1KMT2AALDH1A1
SCHEMBL4843432 0.90 RAB9A (0.54) MAPTTP53MEN1KMT2AALDH1A1
SCHEMBL4841120 0.90 RAB9A (0.48) MAPTTP53MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 MAPT 646/4885TP53 2237/4885L3MBTL1 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.